Image from Google Jackets

Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases / edited by Michael B. A. Oldstone, Hugh Rosen.

By: Oldstone, Michael B. A., editor.
Contributor(s): Rosen, Hugh, editor literario | SpringerLink (Online service)
Material type: materialTypeLabelE-bookSeries: Publisher: Cham, Switzerland : Springer, 2014Description: 1 recurso en línea (VII, 184 p.) : 27 ilustraciones, 22 ilustraciones en color.ISBN: 9783319058795.Subject: Enfermedades infecciosasDDC classification: 616.079 Online resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
The organization of the sphingosine-1-phosphate signaling system -- Structural biology of the S1P1 receptor -- Chemical and genetic tools to explore S1P biology -- S1P control of endothelial integrity -- Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen -- Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule -- Sphingosine-1-phosphate and central nervous system -- RORs in autoimmune disease.
Summary: This volume focuses on the role of sphingosine-1-phosphate (S1P) and its analogs in the induced sequestration of lymphocytes in secondary lymphoid organs or in the microenvironment of tissues involved in infection or autoimmune disease. Initial chapters define the pathways to understand S1P signaling. They cover the organization ofÂ{u0CE9}gnaling systems, the structural biology of the S1P1 receptor, and the chemical and genetic tools that are available and useful to explore this area of research and therapeutics. The later chapters highlight S1P and endothelial integrity, lymphocyte migration in the spleen, and S1P agonist in controlling immunopathologic manifestations of acute respiratory influenza virus infection (in the lung), and its accompanying cytokine storm as well as immunopathologic disease of the central nervous system, including the beginning of treatments in multiple sclerosis.Â{u03EE}e chapter reveals the possible involvement of other lipid molecules, their use for better understanding lipid signaling, and their potential in the modulation of immune responses.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Copy number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud QR1 .O437 2014 EB (Browse shelf(Opens below)) .i11547911 Acceso electrónico eBOOK .i11547911
Total holds: 0

The organization of the sphingosine-1-phosphate signaling system -- Structural biology of the S1P1 receptor -- Chemical and genetic tools to explore S1P biology -- S1P control of endothelial integrity -- Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen -- Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule -- Sphingosine-1-phosphate and central nervous system -- RORs in autoimmune disease.

This volume focuses on the role of sphingosine-1-phosphate (S1P) and its analogs in the induced sequestration of lymphocytes in secondary lymphoid organs or in the microenvironment of tissues involved in infection or autoimmune disease. Initial chapters define the pathways to understand S1P signaling. They cover the organization ofÂ{u0CE9}gnaling systems, the structural biology of the S1P1 receptor, and the chemical and genetic tools that are available and useful to explore this area of research and therapeutics. The later chapters highlight S1P and endothelial integrity, lymphocyte migration in the spleen, and S1P agonist in controlling immunopathologic manifestations of acute respiratory influenza virus infection (in the lung), and its accompanying cytokine storm as well as immunopathologic disease of the central nervous system, including the beginning of treatments in multiple sclerosis.Â{u03EE}e chapter reveals the possible involvement of other lipid molecules, their use for better understanding lipid signaling, and their potential in the modulation of immune responses.

There are no comments on this title.

to post a comment.
Share